Saturday 17 October 2026 Export COLL’s income statement to Excel — free account

Collegium Pharmaceutical, Inc.

COLL Healthcare Drug Manufacturers Specialty & Generic

Collegium Pharmaceutical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $780.6 million, up 23.6% from fiscal 2024. In the quarter to June 2026, revenue grew 6.32%, EPS fell 221.1%, free cash flow fell 2.14% and total debt rose 32.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

23.19 0.01 +0.04%

Follow COLL

Alert me

Market cap: $754.6M
P/E: 15.2×
Fwd P/E: 12.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.58
Beneish M: −3.32
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	23.66	13.95	23.15	18.91	+8 more quarters Free account
P/S ratio Full definition →	1.45	1.33	1.88	1.46
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	16.48	18.58	11.93	14.08
P/B ratio Full definition →	3.77	3.40	4.87	4.02
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	2.62	1.79	2.40	2.12
EV/EBITDA Full definition →	5.42	3.44	4.62	4.21
EV/Operating CF Full definition →	6.42	4.30	5.68	5.52
EV/FCF Full definition →	(53.00)	(37.04)	(46.03)	(20.36)
Quick Ratio Full definition →	0.74	1.54	1.40	1.19
Current Ratio Full definition →	1.03	1.71	1.57	1.36
Net Debt/EBITDA Full definition →	13.77	4.17	3.45	4.24
Debt/Assets Full definition →	51.11%	48.60%	48.85%	50.28%
Debt/Equity Full definition →	3.50	2.57	2.68	2.94
Asset Turnover Full definition →	0.43	0.49	0.47	0.47
Operating CF/Net income Full definition →	(4.74)	3.94	7.25	2.49
Capex/Depreciation Full definition →	(0.01)	0.00	(0.01)	0.00
Interest Coverage Full definition →	0.19	1.95	3.15	2.85
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	53.33%	44.62%	32.92%	32.05%
Intangible Assets out of Total Assets Full definition →	0.64	0.46	0.49	0.54
Share Based Compensation of Revenue Full definition →	7.25%	5.62%	4.75%	4.69%
Graham Net Nets Full definition →	(1.03)	(0.56)	(0.45)	(0.65)
Graham Number Full definition →	18.19	22.79	20.69	19.03
Earnings Yield Full definition →	4.23%	7.17%	4.32%	5.29%
Free Cash Flow Yield Full definition →	(3.40%)	(3.62%)	(2.77%)	(7.14%)
Revenue per Share Full definition →	6.16	6.03	6.48	6.63
Operating CF per Share Full definition →	2.20	1.78	3.88	2.48
Capex per Share Full definition →	(0.02)	(0.01)	(0.02)	(0.01)
Free Cash Flow per Share Full definition →	2.18	1.77	3.86	2.48
Cash per Share Full definition →	4.60	13.76	12.82	9.68
Shareholders Equity per Share Full definition →	9.61	9.74	9.51	8.70
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	9.61	9.74	9.51	8.70
Free Cash Flow Full definition →	70.83	56.84	122.36	78.25
Working Capital Full definition →	18.15	310.70	251.38	160.94
Capital Expenditures Full definition →	(0.50)	(0.27)	(0.69)	(0.19)
Net Current Asset Value Full definition →	(1,215.87)	(593.86)	(663.75)	(718.65)
EV/EBIT Full definition →	13.45	7.53	10.41	10.24
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	7.46	5.62	8.17	7.04
Other line items
Average Receivables Full definition →	249.06	228.74	219.93	231.20
Average Payables Full definition →	10.07	12.34	7.30	5.39
Average Inventory Full definition →	75.71	39.98	38.24	38.04
Average Assets Full definition →	1,864.21	1,641.67	1,660.21	1,621.24
Average Common Equity Full definition →	272.06	273.43	265.26	254.54

Show all line items

Columns are period end dates

Stockrow Weekly